Current share price for RYM : $1.810 0.03 (1.63%)+
--
| ASX Code | RYM |
| Website | http://www.rymanhealthcare.co.nz |
| Industry/Sector | Health Care Facilities |
| Market Cap ($M) | 1,838 |
| RYM Share Price | $1.810 |
| Day High | $1.815 |
| Day Low | $1.810 |
| Last Close | $1.840 |
| RYM Share Price Movement | $0.03 ( 1.63% ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Ryman Healthcare Limited (RYM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Mar | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | C2 | -$5.80 | 0.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 A | 2026 A | 2026 A | ||||||||
| Regis Healthcare Limited (REG) | $1,987M | -6.7687 | 0.0813 | 0.2360 | 37.0977 | 34.3081 | 27.7567 | 2.47% | 2.69% | 3.17% |
| Ramsay Health Care Limited (RHC) | $9,937M | 0.2153 | -0.2767 | 0.4017 | 27.4012 | 37.8861 | 27.0279 | 1.86% | 1.97% | 2.42% |
| Ryman Healthcare Limited (RYM) | $1,869M | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.55 | 0.00 |
| Market | 0.28 | 13.00 | 1.14 | 0.58 |
| Sector | 0.68 | 23.20 | 1.59 | 2.54 |
| Name | Position | Start Date |
|---|---|---|
| Mr Dean Ross Hamilton | Non-Executive Chairman, Non-Executive Director | 1 Jan 0001 |
| Mr James Bruce Miller | Non-Executive Director | 1 Jan 0001 |
| Ms Paula Jeffs | Non-Executive Director | 1 Jan 0001 |
| Mr David Pitman | Non-Executive Director | 1 Jan 0001 |
| Ms Kathryn(Kate) Marian Munnings | Non-Executive Director | 1 Jan 0001 |
| Mr Scott Pritchard | Non-Executive Director | 1 Jan 0001 |
| Mr Hamish Rumbold | Non-Executive Director | 1 May 2026 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Dec 2025 | HAMILTON, Dean | Buy | Direct Shares | 7,253 | $2.940 | $21,323.820 |
See all changes in directors' interest & trades for Ryman Healthcare Limited (RYM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Richard Stephenson | Chief Development and Property Officer |
| Rachna Gandhi | Chief Enterprise Strategy, Systems and Governance Office |
| Naomi James | Chief Executive Officer |
| Matt Prior | Chief Financial Officer |
| Marsha Cadman | Chief Operating Officer |
| Di Walsh | Chief People and Safety Officer |
| Marie Bonnemaison | Chief Transformation and Corporate Development Officer |
| Morgan Powell | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Ryman Healthcare Limited (RYM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 79,223,802 (7.80%) | FirstCape Group Limited |
| 44,042,464 (6.41%) | Forsyth Barr Investment Management Limited |
| Date | Event |
|---|---|
| 04 June 2027 | Report (Annual) |
| 25 May 2027 | Report (Prelim) |
| 26 November 2026 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.